Join us

We're recruiting!

Join Us Page Image 1

By joining the UK DRI you’ll belong to a team of fantastic researchers, technical specialists and professional support staff passionate about accelerating the discovery, development and delivery of interventions that will help diagnose, treat and ultimately prevent dementia, directly benefitting people affected by dementia, their carers, families and the community.

We’re looking for brilliant people with diverse perspectives. Together our unique contributions will transform the range and pace of research on dementia. You’ll be supported by the very best tools and resources and join a culture that encourages high risk/reward science and sharing of ideas.

We are a vibrant, ambitious and interactive community. We offer opportunities at all career levels for scientists and support staff in our seven centres across the UK, as well as in our London-based HQ team.

We’re always interested in hearing from people as passionate about our mission as we are. To find out more about working at the UK DRI or our current opportunities, please contact us at enquiries@ukdri.ac.uk.

Explore all jobs

​UK DRI at UCL

Research at the UK DRI at UCL covers the journey from the person living with dementia to the laboratory and back again - with improved diagnosis and potential therapies put to the test.

  • Specialisms at UCL
  • Mechanistic understanding of dysfunction in cells and neural systems
  • Gene expression and biological pathways in single cells related to the progression of Alzheimer’s disease
  • New biomarkers to monitor disease progression
  • Deficits in axonal transport in early neurodegeneration
  • Wnt signalling in synapses to discover new targets for future dementia therapies
  • Read more about UCL

    From lab bench to bedside, and back again

    UCL was selected as the hub of the UK DRI in 2016 because of its strength to bring together excellent clinical and basic neuroscience research to advance our understanding of neurodegeneration and identify novel targets and therapeutic approaches for dementia. As the hub, it has a larger research programme and also is the location for the national headquarters team who connect the whole institute together.

    Research at the UK DRI at UCL covers the journey from the person living with dementia to the laboratory and back again - with improved diagnosis and potential therapies put to the test. The groups believe in intervening earlier in disease in order to change the trajectory.

    We need to better understand the diversity and complexity of neurodegenerative diseases, like Alzheimer's disease, in order to understand the mechanisms involved, and ultimately how we can alter them to improve people's lives.

    We must find treatments quicker, and that's why the UK DRI at UCL is taking a novel approach by integrating diverse expertise for efficiency, from genetics to diagnostics.

    This work is enhanced by incredible clinical resources. Researchers have access to unique clinical cohorts, where comprehensive data has been collected throughout disease progression including memory assessments and brain tissue. The UK DRI at UCL provides a clinical arm to the whole of the UK DRI.

    The future iconic home of the UK DRI at UCL will be alongside UCL's Queen Square Institute of Neurology in a new building on Gray's Inn Road.

    Visit the UK DRI at UCL local website for up-to-date news.

Apply for latest jobs at UCL

  • Research Fellow, UK DRI at UCL - Bartels lab

    The UK DRI at UCL is seeking a Research Fellow to join the lab of Dr Tim Bartels. Tim Bartels first discovered disease resistant forms of the α-synuclein protein and their destabilisation in Parkinson’s Disease. His lab is interested in identifying the different factors that destabilise α-synuclein and that lead to neurotoxicity. The lab is now looking for a Research Fellow to join them and work on one of the current projects on offer. One project will involve developing antibodies against specific species of α-Synuclein, a protein involved in neurodegeneration, and developing an ELISA or Quanterix detection assay to detect α-Synuclein in different human biofluids (blood, CSF) and establishing a fluid biomarker for Parkinson’s Disease and Dementia with Lewy Bodies. This project will offer the opportunity o work in collaboration with Zetterberg lab at the UK DRI at UCL and Rimona Weil at the National Hospital for Neurology and Neurosurgery. The second project involves investigating the gut-brain axis in PD using mouse models and human synucleinopathy tissue in collaboration with the Soyon Hong lab at the UK DRI. Candidates interested in this project should be familiar with one (or more) of the following: Protein biochemistry (Western, ELISA, IHC), biophysical structure work, protein purification, immune cell signalling. Ref: 1879783, Closing date: 31 July 2022

    Apply to centre

Founding funders

Latest tweets from @UKDRI

RT @ComplementUK: You don’t want to miss this exciting #workshop! Register 𝗯𝗲𝗳𝗼𝗿𝗲 summer holiday, by 25th 𝗔𝘂𝗴𝘂𝘀𝘁! 👉 https://t.co/iirkqVnbb
07 Jul 2022 15:23

RT @CharlotteLuff: I’ll be at #FENS2022 presenting a poster on the biophysics of temporal interference non-invasive deep brain stimulation.…
07 Jul 2022 12:39